Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Champions Oncology (CSBR) Other Non-Current Assets (2016 - 2026)

Champions Oncology (CSBR) has 15 years of Other Non-Current Assets data on record, last reported at $196000.0 in Q4 2025.

  • For Q4 2025, Other Non-Current Assets rose 5.95% year-over-year to $196000.0; the TTM value through Oct 2025 reached $196000.0, up 5.95%, while the annual FY2025 figure was $196000.0, 5.95% up from the prior year.
  • Other Non-Current Assets reached $196000.0 in Q4 2025 per CSBR's latest filing, roughly flat from $196000.0 in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $196000.0 in Q2 2025 and bottomed at $15000.0 in Q2 2021.
  • Average Other Non-Current Assets over 5 years is $106200.0, with a median of $135000.0 recorded in 2021.
  • Peak YoY movement for Other Non-Current Assets: plummeted 88.28% in 2021, then skyrocketed 1133.33% in 2023.
  • A 5-year view of Other Non-Current Assets shows it stood at $15000.0 in 2021, then changed by 0.0% to $15000.0 in 2022, then surged by 1133.33% to $185000.0 in 2023, then changed by 0.0% to $185000.0 in 2024, then rose by 5.95% to $196000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Other Non-Current Assets were $196000.0 in Q4 2025, $196000.0 in Q3 2025, and $196000.0 in Q2 2025.